In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Sabra Healthcare REIT Inc (NASDAQ: SBRA) closed at $19.0 in the last session, down -1.61% from day before closing price of $19.31. In other words, the price has decreased by -$1.61 from its previous closing price. On the day, 4.78 million shares were traded. SBRA stock price reached its highest trading level at $19.44 during the session, while it also had its lowest trading level at $18.8245.
Ratios:
We take a closer look at SBRA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 22.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.66. For the most recent quarter (mrq), Quick Ratio is recorded 1.67 and its Current Ratio is at 1.67. In the meantime, Its Debt-to-Equity ratio is 0.93 whereas as Long-Term Debt/Eq ratio is at 0.93.
Upgrades & Downgrades
In the most recent recommendation for this company, UBS on November 18, 2025, initiated with a Neutral rating and assigned the stock a target price of $20.
On October 01, 2025, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 20 ’25 when FOSTER MICHAEL J sold 11,000 shares for $18.22 per share. The transaction valued at 200,376 led to the insider holds 64,725 shares of the business.
Michael J. Foster bought 11,000 shares of SBRA for $192,500 on May 15 ’25. On Feb 24 ’25, another insider, Cusack Catherine, who serves as the Director of the company, bought 1,500 shares for $15.92 each. As a result, the insider paid 23,880 and bolstered with 60,583 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBRA now has a Market Capitalization of 4737644032 and an Enterprise Value of 7136359936. As of this moment, Sabra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.13, and their Forward P/E ratio for the next fiscal year is 26.00. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.25. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.33 while its Price-to-Book (P/B) ratio in mrq is 1.68. Its current Enterprise Value per Revenue stands at 9.553 whereas that against EBITDA is 15.663.
Stock Price History:
The Beta on a monthly basis for SBRA is 0.65, which has changed by 0.111686826 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, SBRA has reached a high of $19.97, while it has fallen to a 52-week low of $15.60. The 50-Day Moving Average of the stock is 2.99%, while the 200-Day Moving Average is calculated to be 4.74%.
Shares Statistics:
According to the various share statistics, SBRA traded on average about 2.93M shares per day over the past 3-months and 3031520 shares per day over the past 10 days. A total of 249.35M shares are outstanding, with a floating share count of 244.75M. Insiders hold about 1.84% of the company’s shares, while institutions hold 96.18% stake in the company. Shares short for SBRA as of 1764288000 were 23647917 with a Short Ratio of 8.08, compared to 1761868800 on 18879043. Therefore, it implies a Short% of Shares Outstanding of 23647917 and a Short% of Float of 13.149999000000001.
Dividends & Splits
The forward annual dividend rate for SBRA is 1.20, which was 1.2 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.06214397. The stock’s 5-year Average Dividend Yield is 8.04. The current Payout Ratio is 223.55% for SBRA, which recently paid a dividend on 2025-11-17 with an ex-dividend date of 2025-11-17. Stock splits for the company last occurred on 2010-11-16 when the company split stock in a 1:3 ratio.
Earnings Estimates
The dynamic stock of Sabra Healthcare REIT Inc (SBRA) is currently attracting attention from 2.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.17, with high estimates of $0.17 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.71 and $0.67 for the fiscal current year, implying an average EPS of $0.7. EPS for the following year is $0.75, with 2 analysts recommending between $0.77 and $0.73.
Revenue Estimates
According to 5 analysts,. The current quarter’s revenue is expected to be $206.33M. It ranges from a high estimate of $215.57M to a low estimate of $189.5M. As of. The current estimate, Sabra Healthcare REIT Inc’s year-ago sales were $182.35MFor the next quarter, 5 analysts are estimating revenue of $204.07M. There is a high estimate of $227.7M for the next quarter, whereas the lowest estimate is $182.22M.
A total of 6 analysts have provided revenue estimates for SBRA’s current fiscal year. The highest revenue estimate was $778.3M, while the lowest revenue estimate was $719.1M, resulting in an average revenue estimate of $755.71M. In the same quarter a year ago, actual revenue was $703.24MBased on 7 analysts’ estimates, the company’s revenue will be $850.21M in the next fiscal year. The high estimate is $975.79M and the low estimate is $739.68M.
